Brian Andrew
InvestorInvestment Committee Chair at Pathway to Cures
Find your path to Brian
19 people in our graph share verified history with Brian — schools, employers, funds. One of them is your warm intro.
Teri WilleyunlockedBrian: together at Pathway to Cures
×11Brian: together at Pathway to Cures
About
Brian Andrew is a Transformation Engineer at Main Line Health and Communications Manager at Sugati Ventures, a healthtech-focused venture capital firm. He holds a Master's in Health Systems Engineering from Lehigh University, with experience in process improvement, analytics, and simulation modeling applied to clinical settings. He previously led operations and process improvements at a medical product company, where he redesigned fulfillment workflows and developed inventory systems.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Haiyan Jiang
Scientific Advisory Group Member at Pathway to Cures
Frequently asked questions
- Who is Brian Andrew?
- Brian Andrew is a Transformation Engineer at Main Line Health and Communications Manager at Sugati Ventures, a healthtech-focused venture capital firm. He holds a Master's in Health Systems Engineering from Lehigh University, with experience in process improvement, analytics, and simulation modeling applied to clinical settings. He previously led operations and process improvements at a medical product company, where he redesigned fulfillment workflows and developed inventory systems.
- Where does Brian Andrew work?
- Brian Andrew is Investment Committee Chair at Pathway to Cures.





